Evidence map›Paper›PMID 33052874›Full record

ArticleScience advances2020

Interference with pancreatic sympathetic signaling halts the onset of diabetes in mice.

Gustaf Christoffersson, Sowbarnika S Ratliff, Matthias G von Herrath

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. The role of chromogranin A cleavage products in onset of type 1 and 2 diabetes.Frontiers in clinical diabetes and healthcare · 2026
    Review
  4. Article
  5. Article
  6. Islet Tissue Macrophages in Immunity Homeostasis and Type 1 Diabetes.Clinical reviews in allergy & immunology · 2025
    Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Diabetes as a Pancreatic Microvascular Disease-A Pericytic Perspective.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2024
    Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Gustaf ChristofferssonLa Jolla Institute for Immunology, La Jolla, CA 92037, USA. matthias@lji.org gustaf.christoffersson@scilifelab.uu.se.ORCID 0000-0002-9640-9702
Sowbarnika S RatliffLa Jolla Institute for Immunology, La Jolla, CA 92037, USA.
Matthias G von HerrathLa Jolla Institute for Immunology, La Jolla, CA 92037, USA. matthias@lji.org gustaf.christoffersson@scilifelab.uu.se.ORCID 0000-0002-9640-9702
La Jolla Institute for Immunology · USUppsala University · SE

Funding

Specificity, Phenotype and Function of Pancreatic CD8 T Cells in Human Type 1 DiabetesR01AI092453 · NIAID · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Estefania Quesada Masachs · 2011 to 2026
$5.7M
NIAID NIH HHS R01 AI092453
6 · The paper itself

Abstract

The notably lobular distribution of immune lesions in type 1 diabetes (T1D) has been hypothesized to be the result of innervation within the pancreas. To investigate whether neuroimmune interactions could explain this phenomenon, we explored the impact of sympathetic signaling in the RIP-LCMV-GP mouse model of autoimmune diabetes. In this model, the CD8

Indexed as

Diabetes Mellitus, Type 1AnimalsCD8-Positive T-LymphocytesMiceMice, Inbred C57BLMice, TransgenicPancreasReceptors, AdrenergicReceptors, Adrenergic

Identifiers

PMID33052874
PMCPMC7531904
OpenAlexW3080854558

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.